Merger and Acquisition Scenario
Bristol Myers Squibb Co. (BMY) and Human Genome Sciences (HGSI)
| Date: | Feb 11, 2012 |
|---|---|
| Format: | HTML |
| Price: | $250.00 |
Abstract
Revere Data's Merger & Acquisition Scenario Report offers independent, objective and insightful analysis into a hypothetical combination of Bristol Myers Squibb Co. (BMY) with Human Genome Sciences (HGSI) . The Revere report begins by identifying Bristol Myers Squibb Co. products that are either complementary or overlapping to Human Genome Sciences products. Bristol Myers Squibb Co. suppliers are then displayed alongside Human Genome Sciences suppliers, with overlapping suppliers to both firms highlighted. Dependent suppliers to both companies are also displayed, including the percentage of dependent revenue if known. Top Bristol Myers Squibb Co. customers and top Human Genome Sciences customers, including overlapping customers, are also shown. The Revere report then includes key business relationship data in the area of strategic partnerships for each company. Additional content and features include Lines of Business Summaries, Product Summaries, Individual Bristol Myers Squibb Co. Product Line and Human Genome Sciences Product Line Details, Bristol Myers Squibb Co. Earnings and Human Genome Sciences Earnings Summaries, and pro forma financial statements. Revere Data Merger & Acquisition Scenario Reports are an essential source of competitive insight into an array of potential merger, acquisition, takeover, consolidation, rollup or other combination scenarios, with particular focus in the healthcare, biotechnology, information technology, finance and media sectors. Revere's extensive databases on key business relationships, product lines, focused sectors, and financial performance indicators provide a rich and integrated information source for investment banking, corporate finance, C-level executives, management consultants, marketing, and business intelligence professionals who want actionable answers and ideas in seconds.
Report Contents
- Summary
- Lines of Business Summary
- Product Summary
- Overlap & Complementary Sectors
- Sample Products in Similar Lines of Business
- Sample Products in Complementary Lines of Business
- Business Relationship Summary
- Top Key Suppliers
- Top Key Customers
- Key Financial Summary
- Individual Company Summary
- Focused Sector
- Revenue/Earnings Summary
- Business Description
- Product Summary
- Product Details
- Relationship Details
- Key Competitors
- Dependent Suppliers
- Key Customers
- Key Partners
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Companies Mentioned in the Report
- Bristol Myers Squibb Co. (BMY) - Overview - Reports
- Human Genome Sciences (HGSI) - Overview - Reports
More Information:
Learn more about Merger and Acquisition Scenario Report.
Don't see the Scenario report you want? Request Merger and Acquisition Scenario Report »
Download Fact Sheet Merger and Acquisition Scenario (PDF)
Related Reports:
- Merger and Acquisition Scenario for Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Bristol Myers Squibb Co. (BMY)
- Merger and Acquisition Scenario for Bristol Myers Squibb Co. (BMY) and ViroPharma Incorporated (VPHM)
- Merger and Acquisition Scenario for Bristol Myers Squibb Co. (BMY) and King Pharmaceuticals, Inc. (?212886)
- Merger and Acquisition Scenario for Bristol Myers Squibb Co. (BMY) and Momenta Pharmaceuticals, Inc. (MNTA)